Apnimed sees positives in midstage data for its attempt at drugging the sleep apnea problem

Apnimed sees positives in midstage data for its attempt at drugging the sleep apnea problem

Source: 
Fierce Biotech
snippet: 

Just a few months after a modest $25 million raise, little Apnimed has released some broadly positive data for its experimental sleep apnea drug.